VEGFA and neoplasm: Zahnow’s group observed that combining DNA methlytransferase inhibitors with histone deacetylase inhibitors, or with an ornithine decarboxylase inhibitor, can reduce M2 infiltration in tumors, while increasing tumor-killing M1, T- and NK cell activation, thus delaying EOC progression in an ID8 VEGF-expressing mouse model [179,180].